<DOC>
	<DOCNO>NCT02219048</DOCNO>
	<brief_summary>The study propose evaluate safety efficacy PF-03715455 moderate severe asthma add standard care stag withdrawal background therapy .</brief_summary>
	<brief_title>An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma</brief_title>
	<detailed_description>Study terminate 7th April 2015 . The termination due business reason . No safety efficacy concern contribute termination study</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Subjects physician document history diagnosis persistent asthma ( accord GINA , 2014 definition asthma ) , Pre bronchodilator FEV1 great equal 50 less 80 % predict . Subjects define GINA Step 4 stable dose either fluticasone/salmeterol combination therapy , budesonide/formoterol combination therapy mometasone/formoterol combination therapy . Subjects define uncontrolled evidence ; Juniper Asthma Control Questionnaire ( 5 item version , ACQ ) score great equal 1.5 less equal 3.0 ) Subjects diagnose chronic pulmonary disease ( COPD ) and/or chronic pulmonary disease ( eg , Occupational asthma , pulmonary fibrosis , bronchiectasis , Allergic bronchopulmonary aspergillosis ( ABPA ) , pneumoconiosis , sarcoidosis , tuberculosis ) . Subjects current smoker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Staged withdrawal background therapy</keyword>
</DOC>